Literature DB >> 20422171

Management of moderate functional tricuspid valve regurgitation at the time of pulmonary valve replacement: is concomitant tricuspid valve repair necessary?

Brian Kogon1, Manisha Patel, Traci Leong, Michael McConnell, Wendy Book.   

Abstract

Congenital heart defects with a component of pulmonary stenosis are often palliated in childhood by disrupting the pulmonary valve. Patients often undergo subsequent pulmonary valve replacement (PVR) to protect the heart from the consequences of pulmonary regurgitation. In the presence of associated moderate functional tricuspid valve (TV) regurgitation, it is unclear what factors contribute to persistent TV regurgitation following PVR. In particular, it is unknown whether PVR alone will reduce the right ventricular (RV) size and restore TV function or whether concomitant TV annuloplasty is required as well. Thirty-five patients were analyzed. Each patient underwent initial palliation of congenital pulmonary stenosis or tetralogy of Fallot, underwent subsequent PVR between 2002 and 2008, and had at least moderate TV regurgitation at the time of valve replacement. Serial echocardiograms were analyzed. Pulmonary and TV regurgitation, along with RV dilation and dysfunction, were scored (0, none; 1, mild; 2, moderate; 3, severe). RV volume and area were also calculated. Potential risk factors for persistent postoperative TV regurgitation were evaluated. One month following PVR, there was a significant reduction in pulmonary valve regurgitation (mean, 3 vs. 0.39; P < 0.0001) and TV regurgitation (mean, 2.33 vs. 1.3; P < 0.0001). There were also significant reductions in RV dilation, volume, and area. There were no significant further improvements in any of the parameters at 1 and 3 years. There was no difference in the degree of TV regurgitation postoperatively between those patients who underwent PVR alone and those who underwent concomitant tricuspid annuloplasty (mean, 1.29 vs. 1.31; P = 0.81). We conclude that following PVR, improvement in TV regurgitation and RV size occurs primarily in the first postoperative month. TV function improved to a similar degree with or without annuloplasty.

Entities:  

Mesh:

Year:  2010        PMID: 20422171     DOI: 10.1007/s00246-010-9717-6

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  10 in total

Review 1.  Indications and timing of pulmonary valve replacement after tetralogy of Fallot repair.

Authors:  Tal Geva
Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu       Date:  2006

2.  Tricuspid valve repair: durability and risk factors for failure.

Authors:  Patrick M McCarthy; Sunil K Bhudia; Jeevanantham Rajeswaran; Katherine J Hoercher; Bruce W Lytle; Delos M Cosgrove; Eugene H Blackstone
Journal:  J Thorac Cardiovasc Surg       Date:  2004-03       Impact factor: 5.209

Review 3.  Pulmonary regurgitation: not a benign lesion.

Authors:  Beatriz Bouzas; Philip J Kilner; Michael A Gatzoulis
Journal:  Eur Heart J       Date:  2005-01-07       Impact factor: 29.983

4.  Outcomes of tricuspid valve repair and replacement: a propensity analysis.

Authors:  Robert J Moraca; Marc R Moon; Jennifer S Lawton; Tracey J Guthrie; Kristen A Aubuchon; Nader Moazami; Michael K Pasque; Ralph J Damiano
Journal:  Ann Thorac Surg       Date:  2009-01       Impact factor: 4.330

Review 5.  Surgery for functional tricuspid regurgitation: current techniques, outcomes and emerging concepts.

Authors:  Shahzad G Raja; Gilles D Dreyfus
Journal:  Expert Rev Cardiovasc Ther       Date:  2009-01

6.  De Vega tricuspid annuloplasty for tricuspid regurgitation in children.

Authors:  K R Kanter; N R Doelling; D A Fyfe; S Sharma; V K Tam
Journal:  Ann Thorac Surg       Date:  2001-10       Impact factor: 4.330

7.  Follow-up after surgical closure of congenital ventricular septal defect.

Authors:  G Bol-Raap; J Weerheim; A P Kappetein; M Witsenburg; A J J C Bogers
Journal:  Eur J Cardiothorac Surg       Date:  2003-10       Impact factor: 4.191

8.  Tricuspid valve surgery: a thirty-year assessment of early and late outcome.

Authors:  Thomas Guenther; Christian Noebauer; Domenico Mazzitelli; Raymonde Busch; Peter Tassani-Prell; Ruediger Lange
Journal:  Eur J Cardiothorac Surg       Date:  2008-06-25       Impact factor: 4.191

9.  Tricuspid valve detachment in closure of congenital ventricular septal defect.

Authors:  Jinping Zhao; Jun Li; Xiang Wei; Bo Zhao; Wei Sun
Journal:  Tex Heart Inst J       Date:  2003

10.  Closure of isolated ventricular septal defect with detachment of the tricuspid valve.

Authors:  S Tatebe; H Miyamura; H Watanabe; M Sugawara; S Eguchi
Journal:  J Card Surg       Date:  1995-09       Impact factor: 1.620

  10 in total
  4 in total

1.  Comparison of long-term postoperative sequelae in patients with tetralogy of Fallot versus isolated pulmonic stenosis.

Authors:  Michael J Zdradzinski; Athar M Qureshi; Robert Stewart; Gosta Pettersson; Richard A Krasuski
Journal:  Am J Cardiol       Date:  2014-05-02       Impact factor: 2.778

2.  Tricuspid Valve Repair at Pulmonary Valve Replacement in Repaired Tetralogy of Fallot.

Authors:  Jooncheol Min; Jae Gun Kwak; Sungkyu Cho; Eung Re Kim; Jae Hong Lim; Chang-Ha Lee; Woong-Han Kim
Journal:  Pediatr Cardiol       Date:  2021-07-31       Impact factor: 1.655

3.  Tricuspid flow and regurgitation in congenital heart disease and pulmonary hypertension: comparison of 4D flow cardiovascular magnetic resonance and echocardiography.

Authors:  Mieke M P Driessen; Marjolijn A Schings; Gertjan Tj Sieswerda; Pieter A Doevendans; Erik H Hulzebos; Marco C Post; Repke J Snijder; Jos J M Westenberg; Arie P J van Dijk; Folkert J Meijboom; Tim Leiner
Journal:  J Cardiovasc Magn Reson       Date:  2018-01-15       Impact factor: 5.364

4.  Tricuspid Valve Intervention at the Time of Pulmonary Valve Replacement in Adults With Congenital Heart Disease: A Systematic Review and Meta-Analysis.

Authors:  Jef Van den Eynde; Connor P Callahan; Mauro Lo Rito; Nabil Hussein; Horacio Carvajal; Alvise Guariento; Arjang Ruhparwar; Alexander Weymann; Werner Budts; Marc Gewillig; Michel Pompeu Sá; Shelby Kutty
Journal:  J Am Heart Assoc       Date:  2021-12-07       Impact factor: 6.106

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.